{"id":"W4400408753","doi":"10.1200/jco.2024.42.16_suppl.e21518","title":"Long term outcomes of patients with advanced/unresectable melanoma treated with immune checkpoint inhibitors.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"","keywords":"Medicine; Oncology; Ipilimumab; Pembrolizumab; Melanoma; Internal medicine; Nivolumab; PD-L1; Immune checkpoint; Immunotherapy; Cancer; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000404744,0.0001337798,0.0002676453,0.0003510329,0.0004698127,0.0006865871,0.0002288894,0.0004232436,0.00163347],"category_scores_gemma":[0.001320597,0.0001029117,0.0004434655,0.0005319514,0.0001932169,0.0005249235,0.0004653577,0.0005923891,0.0003828426],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005323713,"about_ca_system_score_gemma":0.0003178704,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00209384,"about_ca_topic_score_gemma":0.003071647,"domain_scores_codex":[0.9998093,0.00002857091,0.00002742836,0.00004160688,0.00003295336,0.00006015867],"domain_scores_gemma":[0.9987438,0.0001022806,0.0006762128,0.00003576858,0.00009655077,0.0003453365],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004682971,0.00008204886,0.9933826,0.0000304644,0.00007108258,0.0005652352,0.00006764105,0.0001185937,0.0002007388,0.00001820451,0.0003172621,0.004677965],"study_design_scores_gemma":[0.00003067301,0.0006338627,0.9964784,0.00002643647,0.00009890385,0.001537127,0.0001314197,0.0001877187,0.00006992197,0.00005096186,0.00074837,0.000006311717],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967073,0.001069957,0.00006848359,0.0001517481,0.00001851507,0.00001510982,0.0009127373,0.000003682427,0.00105254],"genre_scores_gemma":[0.9981257,0.0002742586,0.00003027862,0.00007214091,0.00002257183,0.00001278505,0.001146238,0.000001500507,0.0003145167],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00209384,"threshold_uncertainty_score":0.005464494,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0408201708393422,"score_gpt":0.3967738527287622,"score_spread":0.35595368188942,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}